Review published in Duodecim: Lymphatics and the eye

Fri, 28 Aug 2020 00:00:00 +0000

English is overwhelmingly the number one language in science. Nevertheless, sometimes there is a need to target audiences different from academic researchers. In Finland, the bi-weekly Duodecim is arguably the medical journal with the biggest reach among domestic medical professionals. Hence, the idea for a Finnish language review was born. Viewed from three different angles (from the laboratories of Sirpa Loukovaara, Kaisa Lehti, and Michael Jeltsch), we are looking at proliferative diabetic retinopathy (PDR), which is an eye complication that develops slowly over decades in diabetic patients and which is still a major cause of blindness. The treatment of PDR is often less successful than it potentially could be. Importantly, we present also advances in PDR research, from which new ideas might emerge of how to improve current treatment regimens.The original Finnish language version of the review just went online: https://www.duodecimlehti.fi/lehti/2020/16/duo15739 . An English translation is available from Zenodo: https://doi.org/10.5281/zenodo.4005517 .

Lymphatics and the eye

Wed, 12 Feb 2020 00:00:00 +0000

Our shared review about the eye lymphatics has been accepted for publication by Duodecim . In addition to review our current understanding about the eye lymphatics, it focuses on proliferative diabetic retinopathy (PDR). PDR is the advanced stage of diabetic retinopathy, which is one of the slowly developing complications of diabetes and which can result in blindness.It has been known for a long time that damage to the blood vessels in the retina is a central event in the disease development. Antiangiogenic therapy, targeting the major angiogenic growth factor VEGF-A, is a cornerstone of the therapy. However, the recent discovery of lymphatic-type vessels in the disease indicates, that it might be helpful to target also the lymphatic growth factors VEGF-C and VEGF-D. This is my first contribution to an article that is written in Finnish. While I even wrote some of the sentences in Finnish myself, big thanks go to Ani and Timo for weeding out the mistakes. However, my take-home message for similar future endeavors (i.e. writing with a team where key members are not very proficient in the target language) is that one should write everything first in English and then have it translated into the target language. If common languages are concerned, the best tool for the automated translation of scientific articles is DeepL . However, DeepL does not know Finnish, and adding Finnish is certainly not high on the developer’s priority list…

Proliferative Diabetic Retinopathy on Michael’s Domain

Review published in Duodecim: Lymphatics and the eye

Lymphatics and the eye